How to assess drug candidates on tinnitus preclinical models for a successful transition to clinical trials ?

by CILcare | Jul 2, 2020 | Events, Non classé

Sylvie Pucheu will be presenting a webinar on preclinical tinnitus models on July 9, 2020:   Tinnitus is one of the most common hearing disorders, for which there is no drug on the market yet. Dr Sylvie Pucheu, CSO & co-founder of CILcare, will present two...

CILcare extends its expertise to develop solutions for people with vestibular disorders with its partner Vertidiag

by CILcare | Jun 15, 2020 | Events

CILcare, world leading CRO entirely specialized in the field of hearing disorders, announces a strategic partnership with the start-up Vertidiag, a company specialized in balance disorders. By combining their unique know-how, CILcare and Vertidiag can propose a...

Multiple drugs tested against Covid-19 are listed among ototoxic agents

by CILcare | Jun 9, 2020 | Events

Contact our team to know more about studies we can conduct to assess both hearing impairment and tinnitus

CILcare announced among the winners of EIT Health’s Bridgehead Global 2020 program !

by CILcare | Jun 4, 2020 | Events, Non classé

CILcare announced among the winners of EIT Health’s Bridgehead Global 2020 program   Montpellier, 4 June 2020: CILcare, the world’s leading CRO specialized in the field of hearing, is one of the winners of EIT Health’s Bridgehead Global 2020 program and will...

Dementia & hearing loss are closely related

by CILcare | May 29, 2020 | Events

Contact our team to know more about studies we can conduct to assess both hearing and cognitive parameters.